Results 211 to 220 of about 169,813 (342)
LZU‐WZLYCS01 is a novel FGFR3‐targeting ADC for bladder cancer with 7‐ethyl‐9‐fluorocamptothecin (A2) as its cytotoxic payload. LZU‐WZLYCS01 intracellularly releases A2, which targets MAD2L1 to activate the cGAS‐STING pathway and induce tumor cell apoptosis.
Shu Cui +16 more
wiley +1 more source
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Fenghong Zhang +8 more
doaj +1 more source
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]
Zhao B +28 more
europepmc +1 more source
BCOR gene alterations in hematologic diseases.
Sportoletti P, Sorcini D, Falini B.
europepmc +1 more source
L‐cysteine triggers auto‐assembly of POD‐like 3D biomimetic S‐Cu‐S single‐atom nanozymes on MoS2 (MoCC). MoCC shows 16.3‐fold higher catalytic velocity and 17.9‐fold greater affinity than HRP, enabling efficient •OH generation via enhanced electron inversion and transfer.
Wenjie Ma +12 more
wiley +1 more source
Erythrocyte Antibodies in AIDS are associated with mycobacteriosis and hypergammaglobulinemia [PDF]
A. Matuschke +21 more
core +1 more source
Computed tomography findings of pneumonia resistant to empirical therapy in patients with hematologic diseases. [PDF]
Giuliani L +8 more
europepmc +1 more source
Laparoscopic Appendectomy for Acute Appendicitis Complicated by Pancytopenia in Two Patients with Hematologic Diseases. [PDF]
Kojima K +5 more
europepmc +1 more source

